HFMVX
Price
$32.45
Change
+$0.35 (+1.09%)
Updated
Jun 2 closing price
Net Assets
3.62B
PMBCX
Price
$30.26
Change
-$0.18 (-0.59%)
Updated
Jun 2 closing price
Net Assets
24.56B
Interact to see
Advertisement

HFMVX vs PMBCX

Header iconHFMVX vs PMBCX Comparison
Open Charts HFMVX vs PMBCXBanner chart's image
HFMVX vs PMBCX Comparison Chart in %
View a ticker or compare two or three
VS
HFMVX vs. PMBCX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HFMVX is a Buy and PMBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMBCX has more cash in the bank: 24.6B vs. HFMVX (3.62B). HFMVX (0.00) and PMBCX (0.00) have matching dividends . HFMVX was incepted earlier than PMBCX: HFMVX (12 years) vs PMBCX (19 years). PMBCX (1.71) is less costly to investors than HFMVX (0.76). HFMVX is a more actively managed with annual turnover of: 81.00 vs. PMBCX (13.70). HFMVX has a lower initial minimum investment than PMBCX: HFMVX (0) vs PMBCX (1000). HFMVX annual gain was more profitable for investors over the last year : -7.28 vs. PMBCX (-15.11). PMBCX return over 5 years is better than : -9.16 vs. HFMVX (-30.04).
HFMVXPMBCXHFMVX / PMBCX
Total Expense Ratio0.761.7144%
Annual Report Gross Expense Ratio0.761.7144%
Fund Existence12 years19 years-
Gain YTD8.740-7.252-121%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.62B24.6B15%
Annual Yield % from dividends0.000.00-
Returns for 1 year-7.28-15.1148%
Returns for 3 years-0.409.97-4%
Returns for 5 years-30.04-9.16328%
Returns for 10 years13.1253.2025%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GETGX48.02N/A
N/A
Victory Sycamore Established Value R
BRSDX16.51N/A
N/A
MFS Blended Research Small Cap Eq A
USISX20.28N/A
N/A
Victory Income Stock
CIPSX17.31N/A
N/A
Champlain Small Company Adv
SRFMX12.36N/A
N/A
Sarofim Equity